Compare ADMA & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | DHC |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | 647 | 585 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2012 | N/A |
| Metric | ADMA | DHC |
|---|---|---|
| Price | $8.44 | $8.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $25.67 | $8.00 |
| AVG Volume (30 Days) | ★ 2.6M | 1.2M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $42,219,783.00 | N/A |
| Revenue This Year | $27.46 | $3.13 |
| Revenue Next Year | $22.11 | $7.00 |
| P/E Ratio | $45.79 | ★ N/A |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $7.21 | $3.24 |
| 52 Week High | $20.46 | $9.66 |
| Indicator | ADMA | DHC |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 46.85 |
| Support Level | $8.20 | $8.67 |
| Resistance Level | $8.97 | $9.14 |
| Average True Range (ATR) | 0.26 | 0.30 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 28.57 | 22.40 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.